1. Mills KT, Bundy JD, Kelly TN, Reed JE, Kearney PM, Reynolds K, et al. Global disparities of hypertension prevalence and control: a systematic analysis of population-based studies from 90 countries. Circulation. 2016;134(6):441–50.
2. Centers for Disease Control and Prevention. Vital signs: prevalence, treatment, and control of hypertension--United States, 1999–2002 and 2005–2008. MMWR Morbidity and Mortality Weekly Rep. 2011;60(4):103–8.
3. Goldman L, Schafer AI. Goldman’s Cecil medicine E-book: expert consult premium edition--enhanced online features and print, Single Volume: Elsevier Health Sciences; 2011.
4. Chen W, Gao R, Liu L, Zhu M, Wang W, Wang Y, et al. Report on Cardiovascular Diseases in China (2014). In: Xiaoqun H, editor. Encyclopedia of China Publishing House: National Center for Cardiovascular Diseases, China; 2015. p. 182.
5. Wu Y. Research progress on epidemiology of hypertension and its risk factors in Chinese population [in Chinese]. Bull Med R. 2003;32(12):27–9.